| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
4 companies
Sr One Capital Management, LLC is a 10% Owner at Arcellx, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 12 buys and 7 sells.
Estimated insider holdings value: $404.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | ODTX Odyssey Therapeutics, Inc. | 10% Owner | Buy | 555,555 | $18.00 | $9,999,990.00 | +19.4% | - | - | |
| May 11, 2026 | ODTX Odyssey Therapeutics, Inc. | 10% Owner | Sell | 1,780 | $18.00 | $32,040.00 | - | - | - | |
| May 1, 2026 | AVLN Avalyn Pharma Inc. Common Stock | 10% Owner | Buy | 555,555 | $18.00 | $9,999,990.00 | +20.2% | - | - | |
| Oct 9, 2025 | ZBIO Zenas Biopharma, Inc. | 10% Owner | Buy | 126,315 | $19.00 | $2,399,985.00 | +4.3% | -40.5% | - | |
| Sep 16, 2024 | ZBIO Zenas Biopharma, Inc. | 10% Owner | Buy | 2,235,294 | $17.00 | $37,999,998.00 | +83.5% | -51.2% | +1.5% | |
| May 11, 2023 | ACLX Arcellx, Inc. | 10% Owner | Sell | 1,012,833 | $45.01 | $45,589,317.35 | -10.1% | -22.5% | +11.6% | |
| Feb 8, 2022 | ACLX Arcellx, Inc. | 10% Owner | Buy | 1,666,667 | $15.00 | $25,000,005.00 | +43.5% | -52.0% | +75.2% |